Singh Gurdev Dave 13D/13G Filings for Vivos Therapeutics, Inc. (VVOS)

Singh Gurdev Dave 13D and 13G filings for Vivos Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
5:02 pm
Purchase
2021-12-3113GVivos Therapeutics, Inc.
VVOS
Singh Gurdev Dave129,988
14.100%
1,200increase
(+0.93%)
Filing
2021-02-16
2:34 pm
Purchase
2020-12-3113GVivos Therapeutics, Inc.
VVOS
Singh Gurdev Dave128,788
17.700%
128,788increase
(New Position)
Filing